Showing results (1801-1810 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|August 11, 2021
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trialsThierry Landre, Gregoire Justeau, Jean-Baptiste Assié, et al.
Cancer Immunology, Immunotherapy : CII|August 16, 2021
CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALLSarah B Reusing, Dan A Vallera, Angela R Manser, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2020
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockadeMarina Natoli, Nair Bonito, James D Robinson, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2020
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancerYinli Yang, Ling Li, Zhansheng Jiang, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigensL Romani, U Grohmann, F Fazioli, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2022
TCR extracellular domain genetically linked to CD28, 2B4/41BB and DAP10/CD3ζ -engineered NK cells mediates antitumor effectsShance Li, Chaoting Zhang, Luyan Shen, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2022
Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinomaCaroline Laheurte, Evan Seffar, Eléonore Gravelin, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2022
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinomaGuru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, et al.
Cancer Immunology, Immunotherapy : CII|August 24, 2022
Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancerPeng Wu, Zhihui Zhang, Zhaoyang Yang, et al.
Pageof 652